Fuji Forms U.S. Subsidiary

Astaxanthin supplier, Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ, has formed a new U.S.-based subsidiary called FCI Health Science, Inc. The new company, headed by president Charles DePrince, was formed in January with the mission of marketing Fuji’s ingredients to the nutritional, personal care and pharmaceutical industries. The formation of FCI Health Science, Inc. comes on the heels of Fuji’s acquisition of the Swedish company, BioProcess AB (formerly AstaCarotene AB), completing a global network spanning Asia, North America and Europe.